Clinical Nurse Specialist in District Of Columbia Medicare Details, Address, Contact
23 Clinical Nurse Specialist nurses found. Showing 21 - 23
 Madelynn M Lewis, NP Clinical Nurse Specialist - Acute Care Medicare: Medicare Enrolled Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 919-710-3251 |
Susan Elizabeth Sabadash, RN, PMHCNS,PMHNP Clinical Nurse Specialist - Psych/Mental Health, Adult Medicare: Not Enrolled in Medicare Practice Location: 2100 Pennsylvania Ave Nw, Washington, DC 20037 Phone: 202-721-2200 |
Dr. Alice Ball Britt, APRN, PHD Clinical Nurse Specialist - Psych/Mental Health, Adult Medicare: Accepting Medicare Assignments Practice Location: 1001 Lawrence St Ne, Washington, DC 20017 Phone: 202-635-5900 Fax: 202-635-5950 |
News Archive
U.S. FDA posts public health communication about metal-on-metal hip implants use in THA
The U.S. Food and Drug Administration posted a public health communication this week about metal-on-metal hip components to notify the public of the concerns on the use of metal-on-metal hip components used in total hip arthroplasty.
Study suggests new path to make protective malaria vaccine
This study suggests that genetically engineered malaria parasites that are stunted through precise gene deletions (genetically attenuated parasites, or "GAP") could be used as a vaccine that protects against malaria infection. This means that the harmless (attenuated) version of the parasite would interact with the body in the same way as the infective version, but without possibility of causing disease.
New medical instruments with smart sensors can improve surgery, therapy for cardiac diseases
Researchers developed a new class of medical instruments equipped with an advanced soft electronics system that could dramatically improve the diagnoses and treatments of a number of cardiac diseases and conditions.
Recent developments at Burnham Institute for Medical Research
New antibiotics for methicillin-resistant Staphylococcus aureus (MRSA) and other pesky bacteria. Andrei Osterman and collaborators have used comparisons of bacterial genomes to identify new targets for antibiotics and produced first-generation chemical inhibitors of a class of bacterial enzymes, called NadDs (nicotinate mononucleotide adenylyltransferases).
Welichem announces filing of clinical trial application with Health Canada
Welichem Biotech Inc. (the "Company") announces the filing with Health Canada of a clinical trial application for its lead, anti-inflammatory drug WBI-1001. The application is for a 3-month, double blinded clinical trial in patients with chronic atopic dermatitis at three trial centres.
› Verified 3 days ago
- 1
- 2(current)